HK1164140A1 - Sublingual spray formulation comprising dihydroartemesinin - Google Patents

Sublingual spray formulation comprising dihydroartemesinin

Info

Publication number
HK1164140A1
HK1164140A1 HK12104912.3A HK12104912A HK1164140A1 HK 1164140 A1 HK1164140 A1 HK 1164140A1 HK 12104912 A HK12104912 A HK 12104912A HK 1164140 A1 HK1164140 A1 HK 1164140A1
Authority
HK
Hong Kong
Prior art keywords
dihydroartemesinin
spray formulation
sublingual spray
sublingual
formulation
Prior art date
Application number
HK12104912.3A
Other languages
English (en)
Chinese (zh)
Inventor
喀爾文．約翰．羅斯
Original Assignee
倫敦制藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0906971.7A external-priority patent/GB2469791B/en
Priority claimed from PCT/GB2009/050415 external-priority patent/WO2010122275A1/en
Application filed by 倫敦制藥有限公司 filed Critical 倫敦制藥有限公司
Publication of HK1164140A1 publication Critical patent/HK1164140A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HK12104912.3A 2009-04-23 2012-05-18 Sublingual spray formulation comprising dihydroartemesinin HK1164140A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0906971.7A GB2469791B (en) 2009-04-23 2009-04-23 Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
PCT/GB2009/050415 WO2010122275A1 (en) 2009-04-23 2009-04-23 Pharmaceutical preparation
PCT/GB2010/050672 WO2010122356A1 (en) 2009-04-23 2010-04-23 Sublingual spray formulation comprising dihydroartemesinin

Publications (1)

Publication Number Publication Date
HK1164140A1 true HK1164140A1 (en) 2012-09-21

Family

ID=42244197

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12104912.3A HK1164140A1 (en) 2009-04-23 2012-05-18 Sublingual spray formulation comprising dihydroartemesinin

Country Status (24)

Country Link
US (4) US20120157518A1 (pt)
EP (1) EP2424523B1 (pt)
JP (1) JP5795760B2 (pt)
CN (1) CN102395362B (pt)
AU (1) AU2010240654C1 (pt)
BR (1) BRPI1014887A8 (pt)
CA (1) CA2756925A1 (pt)
DK (1) DK2424523T3 (pt)
ES (1) ES2390046T3 (pt)
HK (1) HK1164140A1 (pt)
HR (1) HRP20120711T1 (pt)
IL (1) IL215453A (pt)
ME (1) ME02008B (pt)
MX (1) MX2011010961A (pt)
MY (1) MY155646A (pt)
NZ (1) NZ595469A (pt)
PL (1) PL2424523T3 (pt)
PT (1) PT2424523E (pt)
RS (1) RS52430B (pt)
RU (1) RU2501550C2 (pt)
SG (1) SG175162A1 (pt)
SI (1) SI2424523T1 (pt)
WO (1) WO2010122356A1 (pt)
ZA (1) ZA201107088B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
SG175160A1 (en) * 2009-04-23 2011-11-28 Londonpharma Ltd Sublingual pharmaceutical composition comprising a neutral oil
CN105142631A (zh) * 2013-01-14 2015-12-09 健康诊所有限公司 抗癌药物和用途
WO2016083827A1 (en) 2014-11-27 2016-06-02 Cipla Limited Pharmaceutical composition comprising an artemisinin derivative for nasal or pulmonary delivery
JP2020033304A (ja) * 2018-08-30 2020-03-05 医療法人ふじいやさか 薬剤又はサプリメント、組成物、及び水素供給器の使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
IL140402A0 (en) * 1998-07-14 2002-02-10 Bayer Ag Antiparasitic artemisinin derivatives (endoperoxides)
WO2002053138A2 (en) * 2001-01-02 2002-07-11 Elisabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
US20060257463A1 (en) * 2002-05-31 2006-11-16 University Of Mississippi Transmucosal delivery of cannabinoids
AU2003243418B2 (en) * 2002-06-06 2009-02-19 University Of Washington Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
WO2004075921A1 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Inclusion complex of artemisinin or derivates thereof with cyclodextrins
US20060084675A1 (en) * 2004-10-18 2006-04-20 Thomas Efferth Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor
US20060233895A1 (en) * 2005-04-15 2006-10-19 Brown Paul R Herbal remedy for treating Lyme disease
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
CN100418524C (zh) * 2005-10-26 2008-09-17 重庆医药工业研究院有限责任公司 一种稳定的青蒿素及青蒿素衍生物的药物组合物

Also Published As

Publication number Publication date
AU2010240654A1 (en) 2011-10-20
IL215453A (en) 2014-11-30
US20120157518A1 (en) 2012-06-21
US20160022629A1 (en) 2016-01-28
SG175162A1 (en) 2011-11-28
HRP20120711T1 (hr) 2012-10-31
ES2390046T3 (es) 2012-11-06
RS52430B (en) 2013-02-28
MX2011010961A (es) 2012-04-20
CA2756925A1 (en) 2010-10-28
SI2424523T1 (sl) 2012-11-30
MY155646A (en) 2015-11-13
EP2424523A1 (en) 2012-03-07
RU2011139637A (ru) 2013-05-27
BRPI1014887A8 (pt) 2019-02-12
EP2424523B1 (en) 2012-06-27
ZA201107088B (en) 2012-12-27
ME02008B (me) 2013-02-28
CN102395362A (zh) 2012-03-28
IL215453A0 (en) 2011-12-29
AU2010240654B2 (en) 2014-05-08
US20170368023A1 (en) 2017-12-28
NZ595469A (en) 2013-10-25
PL2424523T3 (pl) 2012-11-30
PT2424523E (pt) 2012-10-03
BRPI1014887A2 (pt) 2016-04-19
US20190142737A1 (en) 2019-05-16
CN102395362B (zh) 2014-07-02
DK2424523T3 (da) 2012-09-24
AU2010240654C1 (en) 2014-08-14
JP2012524772A (ja) 2012-10-18
RU2501550C2 (ru) 2013-12-20
JP5795760B2 (ja) 2015-10-14
WO2010122356A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
HRP20180429T1 (hr) Raspršivač
GB2476835B (en) Spray nozzle
EP2492018A4 (en) SPRAY GUN
EP2349912A4 (en) CHEMILUMINESCENT AEROSOL SPRAY
GB201002573D0 (en) Spray gun
EP2459663A4 (en) COATING COMPOSITIONS
EP2415690A4 (en) SPRAY BUTTON
GB2475393B (en) Aerosol spray device
GB0907003D0 (en) Formulation
GB2476836B (en) Spray nozzle
GB0912201D0 (en) Coating compositions
EP2413905A4 (en) COMPOSITION
HK1164140A1 (en) Sublingual spray formulation comprising dihydroartemesinin
EP2392475A4 (en) ANSTRICHFARBENSET
AU324571S (en) Spray cap
HK1173404A1 (en) Spray head
ZA201202039B (en) Spray coating device
GB0911213D0 (en) Formulation
PL2485849T3 (pl) Zraszacz
GB2461575B (en) Spray nozzles
GB0907410D0 (en) Formulation
GB0902472D0 (en) Formulation
GB0906291D0 (en) Formulation
AU329159S (en) Nozzle
GB0910399D0 (en) Nozzle

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210427